TBPH Guided for $75M in Milestones While Trial Risk Went Unquantified -- LEVI & KORSINSKY, LLP
Theravance Biopharma Reaffirmed Financial Guidance Repeatedly Without Disclosing the Material Risk That Its Pivotal Trial Could Fail NEW YORK, March 18, 2026 /PRNewswire/ -- Theravance Biopharma (NASDAQ: TBPH) shareholders lost approximately 26% when shares collapsed on March 3, 2026. In...
CP
cision pr newswire
via Pr Newswire
Updated 20h ago

Source Verification
Corroboration Score: 1This story was independently reported by 1 sources. Click any source to read the original article.
Comments
0 commentsBe respectful and constructive.
Loading comments...
Previous
NBA Power Rankings: Thunder looking dominant again, streaking Lakers up to No. 3
Next
Ranking 2025 MLB playoff teams that are most likely to miss the postseason in 2026
Related Articles
CrimeMasked gunman kills Loyola Chicago college student in shooting near campus; police hunt for suspect
Stepheny Price-3h ago-1 sources
CrimeBecause I Got High star Afroman wins £3m legal case against cops he mocked
Andrea Oldereide-6h ago-1 sources
Miami police betrayed moms of murdered teens, then sent $1,831 bill, suit says
Brittany Wallman-8h ago-1 sources